Technical Analysis for ORTX - Orchard Therapeutics plc

Grade Last Price % Change Price Change
grade F 13.35 -5.59% -0.79
ORTX closed down 5.59 percent on Monday, June 24, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ORTX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Reversal New Lows Setup Bearish Swing Setup -5.59%
Outside Day Range Expansion -5.59%
Wide Bands Range Expansion -5.59%
Down 3 Days in a Row Weakness -5.59%
Down 4 Days in a Row Weakness -5.59%

Older signals for ORTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies. Orchard’s advanced portfolio of autologous ex vivo gene therapies targets serious and life-threatening rare diseases, initially primary immune deficiencies, neurometabolic disorders and hemoglobinopathies.
Biotechnology Health Biopharmaceutical Nature Therapy Hemoglobinopathies
Is ORTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 10 Orchard Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference on June 12, 2019
Jun 6 The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering
Jun 6 Orchard Therapeutics prices stock offering
Jun 5 Orchard Therapeutics Announced Pricing of Public Offering
Jun 4 Mid-Afternoon Market Update: Digital Turbine Surges On Upbeat Earnings; Millicom International Shares Drop
Jun 4 Microcaps dominate midday movers
Jun 4 CEL-SCI and BIOLASE among healthcare gainers; Navidea Biopharmaceuticals leads the losers
Jun 4 Orchard Therapeutics readies stock offering
Jun 3 Orchard Therapeutics Launches Proposed Public Offering
Jun 3 Health Care Digest: Why California biotech thrives, small company looks to crash NASH bash, meeting up at BIO
See more ORTX news...
Indicators
Indicator Value
52 Week High 21.64
52 Week Low 8.65
Average Volume 223,297
200-Day Moving Average 0.0
50-Day Moving Average 17.5394
20-Day Moving Average 15.577
10-Day Moving Average 14.458
Average True Range 0.9943
ADX 34.11
+DI 9.1265
-DI 27.4169
Chandelier Exit (Long, 3 ATRs ) 16.1071
Chandelier Exit (Short, 3 ATRs ) 16.0429
Upper Bollinger Band 19.1868
Lower Bollinger Band 11.9672
Percent B (%b) 0.19
BandWidth 46.347821
MACD Line -1.131
MACD Signal Line -1.046
MACD Histogram -0.085
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.97
Resistance 3 (R3) 15.05 14.60 14.70
Resistance 2 (R2) 14.60 14.18 14.56 14.61
Resistance 1 (R1) 13.97 13.93 13.75 13.89 14.52
Pivot Point 13.52 13.52 13.40 13.48 13.52
Support 1 (S1) 12.89 13.10 12.67 12.81 12.18
Support 2 (S2) 12.44 12.85 12.40 12.09
Support 3 (S3) 11.81 12.44 12.00
Support 4 (S4) 11.73